A graftless maxillary sinus lifting approach with simultaneous dental implant placement: a prospective clinical study.
Mohammed M Albadani, Sadam Ahmed Elayah, Mohammed Ali Al-Wesabi...
https://pubmed.ncbi.nlm.nih.gov/38350895Actively Recruiting
Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID07424742
Transcrestal Graftless Schneiderian Membrane Elevation with Self-tapping Dental Implant Placement
Led by Sana'a University · Updated on 2026-06-02
20
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a minimally invasive graftless sinus lifting technique using a transcrestal approach combined with dental implant placement in patients who have an edentulous posterior maxilla with limited residual bone height. This study aims to assess the efficiency, safety, and reliability of this approach by examining bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival. The treatment involves elevating the sinus membrane without using any graft material, relying instead on blood clot formation and natural bone regeneration. Participants with about 4 to 6 mm of residual bone height in the posterior maxilla will receive a dental implant measuring 10 mm in length and 4 to 4.5 mm in diameter during the procedure. This implant placement occurs simultaneously with the sinus membrane elevation. Participants will undergo radiographic and clinical evaluations before surgery, immediately after the procedure, and six months later to monitor bone formation and implant stability. The primary outcome measured is the amount of newly formed bone six months after surgery. Participants are expected to attend follow-up visits as part of the study's monitoring process, which extends through the six-month postoperative period.
CONDITIONS
Brief Title
Graftless TSFE Via Self-tapping Implants
Who Can Participate
Age: 18Years - 80Years
All Genders
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 80 years
- Patients with edentulous posterior maxilla
- Residual bone height approximately 4 to 6 millimeters
- Indicated for transcrestal sinus membrane elevation
- Good general health (ASA I or II)
- Ability to provide written informed consent
- Willingness to attend follow-up visits
You will not qualify if you...
- Severe systemic diseases (ASA III or above)
- Uncontrolled diabetes mellitus
- Active sinus pathology
- History of radiotherapy in the head and neck region
- Heavy smokers (more than 10 cigarettes per day)
- Pregnancy or lactation
- Untreated periodontal disease
- Poor oral hygiene
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 1 day
Participants undergo a minimally invasive graftless transcrestal sinus membrane elevation followed by simultaneous placement of a dental implant in the posterior maxilla.
1 procedure visit (in-person)
Post-operative Follow-up
Duration - 6 months
Participants return for radiographic and clinical evaluations to assess bone formation, implant stability, and osseointegration.
2 visits (immediately post-operative and 6 months post-operative, in-person)
Trial Site Locations
Total: 1 location
1
Department of Oral and Maxillofacial Surgery, Sana'a University
Sanaa, Sanaa Governorate, Yemen, 00000
Actively Recruiting
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here